famotidine has been researched along with A-V Dissociation in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugiyama, A | 1 |
| Satoh, Y | 1 |
| Takahara, A | 1 |
| Nakamura, Y | 1 |
| Shimizu-Sasamata, M | 1 |
| Sato, S | 1 |
| Miyata, K | 1 |
| Hashimoto, K | 1 |
| Schoenwald, PK | 1 |
| Sprung, J | 1 |
| Abdelmalak, B | 1 |
| Mraović, B | 1 |
| Tetzlaff, JE | 1 |
| Gurm, HS | 1 |
2 other studies available for famotidine and A-V Dissociation
| Article | Year |
|---|---|
Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems.
Topics: Action Potentials; Animals; Cation Transport Proteins; Cell Line; DNA-Binding Proteins; Dogs; Electr | 2003 |
Complete atrioventricular block and cardiac arrest following intravenous famotidine administration.
Topics: Anti-Ulcer Agents; Famotidine; Heart Arrest; Heart Block; Histamine H2 Antagonists; Humans; Injectio | 1999 |